2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
5
Neoplasms
3
Prostatic Neoplasms
2
Pain, Postoperative
2
Pain
2
Neuroma
2
Chronic Pain
2
Breast Diseases
2
Wounds and Injuries
1
Stroke
1
Stomach Neoplasms
1
Spinal Cord Injuries
1
Skin Diseases
1
Rectal Neoplasms
1
Prostatic Hyperplasia
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Muscular Atrophy
1
Muscle Spasticity
1
Lower Urinary Tract Symptoms
1
Low Anterior Resection Syndrome
1
Hereditary leiomyomatosis and renal cell cancer
1
Head and Neck Neoplasms
1
Gastroparesis
1
Ganglion Cysts
1
Esophageal Neoplasms
1
Esophageal Motility Disorders
1
Esophageal Diseases
1
Esophageal Achalasia
1
Cluster Headache
1
Interventions
Nutrition Assessment
3
Transcranial Direct Current Stimulation
2
urinastatin
1
tocilizumab
1
rimabotulinumtoxinB
1
X-Rays
1
Vitamin B 6
1
Vitamin B 12
1
Thrombectomy
1
Standard of Care
1
Saline Solution
1
Rosuvastatin Calcium
1
Resistance Training
1
Practice Guidelines as Topic
1
Phenylephrine
1
Palliative Care
1
Norepinephrine
1
Neuropsychological Tests
1
Music Therapy
1
Massage
1
Lysine Acetyltransferase 5
1
Infliximab
1
Immunoglobulin G
1
Hematologic Tests
1
Folic Acid
1
Extracorporeal Shockwave Therapy
1
Exergaming
1
Enoxaparin
1
Disulfides
1
Dialectical Behavior Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stroke
×
Botulinum Toxins, Type A
×
Clear all
NCT02052024
2015-12-16
MAS
Georgetown University
Phase 4
Completed
10 enrolled